“Advanced Wound Care market set to grow to $13.8bn by 2024” says Visiongain report

03 October 2019
Pharma

Visiongain has published a new pharma report Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies.

Wound care is essential in improving the quality of life and overall well-being. The wound care industry is highly competitive and diverse with immense potential for growth. Drivers for growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness.

The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years.

This report profiled the selected companies: Smith & Nephew, Acelity L.P. Inc., Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, 3M Company, B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc. and other companies.

The lead analyst commented that "Being the largest and fastest growing segment of the wound care market, the Advanced wound care market will witness healthy growth during the forecast period. Growth in this market is set to be driven by the increasing awareness of current technologies, launch of new innovative products and rapidly expanding emerging economies. During the course of the forecast period, more companies are expected to expand their operations into developing economies."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

A Breakdown of Biosimilar Market Size, Benefits & Challenges

Biosimilars were developed to give consumers more affordable options when it comes to purchasing medicine. In the simplest of terms, they’re a copy of an already existing biological medicine in the marketplace that has been thoroughly tested and deemed safe for use. As the need for more access to healthcare and affordable medicine continues to increase, so has the global …

08 October 2019

Read

“Global Surgical Sutures market set to grow to $6.4bn by 2024” says new Visiongain report

The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally.

08 October 2019

Read

“Gastrointestinal Therapeutics market set to grow to $68bn by 2028” says new Visiongain report

Emerging economies of Asia-Pacific and LAMEA possess high potential for gastrointestinal drugs.

04 October 2019

Read

“Advanced Wound Care market set to grow to $13.8bn by 2024” says Visiongain report

Being the largest and fastest growing segment of the wound care market, the Advanced wound care market will witness healthy growth during the forecast period.

03 October 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever